Overall survival of specific HCC patient subgroups in prospective, non-interventional INSIGHT study treated with sorafenib Posted on 1. Februar 201318. Mai 2017 by friebelwv Autoren: Koschny R., Schott E., Galle P.R., Göhler T., Malfertheiner P., Stauber R., Buder R., Bernard I., Gerken G. ESMO 2013